(Date:1/6/2009)...ge, Md. An international group of scientists is l...eas to an increase in the number of harmful algal ...l blooms (HAB,s) occur, they taint seafood with to... and cause fish or mammal kills in coastal waters....ful Algae , scientists present a compilation of 21...
(Date:1/6/2009)... The January issue of the Journal of the America...focusing on everyday eating habits of consumers. R... meet the nutritional needs of preschool children ...diets of young adults. , Packing a Lunch for Pr...y 13 million children in the United States eat thr...
(Date:1/6/2009)...am, January 6, 2009 Elsevier, a leading global hea...e four finalists chosen in the Elsevier Grand Chal...type tools dealing with the ever-increasing amount...iergrandchallenge.com ). The semifinalist round w...itute of Technology in Boston and featured each of...
(Date:1/6/2009)...ochelle, NY, January 6, 2009Dedicated to the memor...man, who pioneered the fields of angiogenesis and ...blood supply and neoplastic disease, the newly rel...of Lymphatic Research and Biology includes a ser...one of the pre-eminent physician-scientists of his...
Breaking Biology News(10 mins):News from the January 2009 Journal of the American Dietetic Association 2Finalists announced in the Elsevier Grand Challenge 2Finalists announced in the Elsevier Grand Challenge 3Festschrift Issue honoring Judah Folkman, M.D. in Lymphatic Research and Biology 2Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke 1049 1Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke 1049 2Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke 1049 3Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke 1049 4Active compounds found in Ganoderma lucidum fungus with potential to treat prostate cancer 8119 1Active compounds found in Ganoderma lucidum fungus with potential to treat prostate cancer 8119 2UQ health and medical researchers recognized in awards 8116 1UQ health and medical researchers recognized in awards 8116 2Fuel cells help make noisy hot generators a thing of the past 1557 1Fuel cells help make noisy hot generators a thing of the past 1557 2(Date:1/7/2009)...wswire/ -- Dr. Ryan Burnette, Director of Alliance...e January 19, 2009 through January 23, 2009. Dr. ...nal accreditation processes for high-containment b...curity and biosafety preparedness program. , ,...ive country that has embraced the need for well-de...
(Date:1/7/2009)... Abaxis, Inc. (Nasdaq: ...oint-of-care blood analysis instruments for both t... that it has entered into a license agreement for ...al health diagnostics in the professional marketpl... flow immunoassay devices and methods. , , This...
(Date:1/6/2009)...wire-FirstCall/ -- Cell Therapeutics, Inc. (CTI),... received notification that,the NASDAQ Listing Qu...ansfer,the listing of its common stock from The N... which will be effective with the open of trading ...ontinue to trade under the ticker symbol,CTIC. ,...
(Date:1/6/2009)... 6 Cell Biosciences, Inc., a,prov...ence researchers, today,announced the placement o...type, the Cell Biosciences CB1000, at the Stanfor...rg, Ph.D., Director of the Human Immune Monitoring...otein activation in a variety of,human clinical s...
Breaking Biology Technology:Alliance Biosciences Announces Trade Mission to Singapore with Speaker Presentation at International Lab Design Seminar 2Alliance Biosciences Announces Trade Mission to Singapore with Speaker Presentation at International Lab Design Seminar 3ABAXIS Announces Worldwide Animal Health Licensing Agreement for Rapid Test Technology 2ABAXIS Announces Worldwide Animal Health Licensing Agreement for Rapid Test Technology 3Cell Therapeutics Announces Receipt of NASDAQ Panel Decision to Transfer to NASDAQ Capital Market 2Cell Therapeutics Announces Receipt of NASDAQ Panel Decision to Transfer to NASDAQ Capital Market 3Cell Biosciences Delivers Next Generation System to Stanford University 2...is. -- The National Institute for General Medical ... SBIR Phase II grant, while the National Cancer In...ase I grant, the Madison-based company reported Th... be for the continued development, optimization an...sulfotransferases. , ,Sulfotransferase enzymes pla...
..., Wis. - Another dismal report on venture capital...wondering what the state must do to attract more p.... An interested observer in that debate could turn.... , ,The agenda for this week,s meeting of the inv...ension fund in the United States, includes a discu...
...ing companies are the "silent partners" of every o...a natural extension of your business. A bad one co...t part of doing business online is finding the rig...he server space, database and internet connectivit...cation, location, location ,From a customer,s per...
...Wis. -- Distance learning is about more than just...sroom, says Michael Schrage. Rather, technology is...what is taught, how it is taught, and what the rel... the information itself. , ,Schrage, a research as...b,s E-Markets Initiative, addressed the recent Dis...
Other Biology Technology:BellBrook Labs gets major research funding 2State investment board keeps an eye on Wisconsin's tech trends 2State investment board keeps an eye on Wisconsin's tech trends 3Silent partners: Selecting a web hosting company 2Silent partners: Selecting a web hosting company 3Silent partners: Selecting a web hosting company 4Schrage: Don't think of distance learning as just automation 2Schrage: Don't think of distance learning as just automation 3...is an excellent choice for supporting hydrocarbon ...al-channel GC, this one-channel workhorse can doub...ace of one. You get all the capability and reliabi...ment that has the same proven performance of Agile...
...rld-class performance hardware, Cerity Networked D...orld-renowned support and columns, as well as our ...n that lets you reach uncompromising results and m...data. The Agilent 6820 GC system is not available ...
...ublication of the best-selling first edition of Dr...Handbook, there have been many highly significant ...on of the level of attention currently afforded pr...s directed to study them, Dr. Walker has completed...
...en call for critical, but time-consuming optimizat...efines siRNA transfection protocols resulting in l...ation can be used to efficiently transfect adheren... cytotoxicity. From start to finish, successful ge...
Biology Products: